Prostate Cancer
ASCL1 regulates and cooperates with FOXA2 to drive terminal neuroendocrine phenotype in prostate cancer.
December 3, 2024
Preoperative Briganti Nomogram Score and Risk of Prostate Cancer Progression After Robotic Surgery Beyond EAU Risk Categories.
December 3, 2024
Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibition.
December 2, 2024
Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function.
December 2, 2024
Hugo™ Versus daVinci™ Robot-Assisted Radical Prostatectomy: 1-Year Propensity Score-Matched Comparison of Functional and Oncological Outcomes.
December 2, 2024
Functional inversion of circadian regulator REV-ERBα leads to tumorigenic gene reprogramming.
November 29, 2024
Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer.
November 29, 2024
Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm.
November 29, 2024
Active surveillance follow-up for prostate cancer: from guidelines to real-world clinical practice.
November 29, 2024
Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies.
November 29, 2024
Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer.
November 28, 2024